These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 25689019)

  • 1. Pharmacological stress is required for the anti-alcohol effect of the α3β4* nAChR partial agonist AT-1001.
    Cippitelli A; Brunori G; Gaiolini KA; Zaveri NT; Toll L
    Neuropharmacology; 2015 Jun; 93():229-36. PubMed ID: 25689019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The α3β4 nAChR partial agonist AT-1001 attenuates stress-induced reinstatement of nicotine seeking in a rat model of relapse and induces minimal withdrawal in dependent rats.
    Yuan M; Malagon AM; Yasuda D; Belluzzi JD; Leslie FM; Zaveri NT
    Behav Brain Res; 2017 Aug; 333():251-257. PubMed ID: 28693859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of alcohol taking and seeking by antagonism at α4β2 and α3β4 nAChRs.
    Cippitelli A; Brunori G; Schoch J; Armishaw CJ; Wu J; Zaveri NT; Giulianotti MA; Welmaker GS; Toll L
    Psychopharmacology (Berl); 2018 Jun; 235(6):1745-1757. PubMed ID: 29572652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in mechanisms underlying reinstatement of cigarette smoke extract- and nicotine-seeking behavior in rats.
    Cross SJ; Reynaga DD; Cano M; Belluzzi JD; Zaveri NT; Leslie FM
    Neuropharmacology; 2020 Jan; 162():107846. PubMed ID: 31704271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AT-1001: a high-affinity α3β4 nAChR ligand with novel nicotine-suppressive pharmacology.
    Cippitelli A; Wu J; Gaiolini KA; Mercatelli D; Schoch J; Gorman M; Ramirez A; Ciccocioppo R; Khroyan TV; Yasuda D; Zaveri NT; Pascual C; Xie XS; Toll L
    Br J Pharmacol; 2015 Apr; 172(7):1834-45. PubMed ID: 25440006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial agonists of the α3β4* neuronal nicotinic acetylcholine receptor reduce ethanol consumption and seeking in rats.
    Chatterjee S; Steensland P; Simms JA; Holgate J; Coe JW; Hurst RS; Shaffer CL; Lowe J; Rollema H; Bartlett SE
    Neuropsychopharmacology; 2011 Feb; 36(3):603-15. PubMed ID: 21048701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tendency to sign-track predicts cue-induced reinstatement during nicotine self-administration, and is enhanced by nicotine but not ethanol.
    Versaggi CL; King CP; Meyer PJ
    Psychopharmacology (Berl); 2016 Aug; 233(15-16):2985-97. PubMed ID: 27282365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AT-1001: a high affinity and selective α3β4 nicotinic acetylcholine receptor antagonist blocks nicotine self-administration in rats.
    Toll L; Zaveri NT; Polgar WE; Jiang F; Khroyan TV; Zhou W; Xie XS; Stauber GB; Costello MR; Leslie FM
    Neuropsychopharmacology; 2012 May; 37(6):1367-76. PubMed ID: 22278092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orexin/hypocretin-1 receptor antagonism reduces ethanol self-administration and reinstatement selectively in highly-motivated rats.
    Moorman DE; James MH; Kilroy EA; Aston-Jones G
    Brain Res; 2017 Jan; 1654(Pt A):34-42. PubMed ID: 27771284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The delta opioid receptor antagonist, SoRI-9409, decreases yohimbine stress-induced reinstatement of ethanol-seeking.
    Nielsen CK; Simms JA; Bito-Onon JJ; Li R; Ananthan S; Bartlett SE
    Addict Biol; 2012 Mar; 17(2):224-34. PubMed ID: 21309957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Administration of the nicotinic acetylcholine receptor agonists ABT-089 and ABT-107 attenuates the reinstatement of nicotine-seeking behavior in rats.
    Lee AM; Arreola AC; Kimmey BA; Schmidt HD
    Behav Brain Res; 2014 Nov; 274():168-75. PubMed ID: 25128791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Nicotinic α6-Subunit Selective Antagonist bPiDI Reduces Alcohol Self-Administration in Alcohol-Preferring Rats.
    Srisontiyakul J; Kastman HE; Krstew EV; Govitrapong P; Lawrence AJ
    Neurochem Res; 2016 Dec; 41(12):3206-3214. PubMed ID: 27573375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nociceptin/orphanin FQ receptor agonist SR-8993 as a candidate therapeutic for alcohol use disorders: validation in rat models.
    Aziz AM; Brothers S; Sartor G; Holm L; Heilig M; Wahlestedt C; Thorsell A
    Psychopharmacology (Berl); 2016 Oct; 233(19-20):3553-63. PubMed ID: 27515665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Escalated Alcohol Self-Administration and Sensitivity to Yohimbine-Induced Reinstatement in Alcohol Preferring Rats: Potential Role of Neurokinin-1 Receptors in the Amygdala.
    Nelson BS; Fulenwider HD; Nennig SE; Smith BM; Sequeira MK; Chimberoff SH; Richie CT; Cheng K; Rice KC; Harvey BK; Heilig M; Schank JR
    Neuroscience; 2019 Aug; 413():77-85. PubMed ID: 31242442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the kappa-opioid receptor system in stress-induced reinstatement of nicotine seeking in rats.
    Grella SL; Funk D; Coen K; Li Z; Lê AD
    Behav Brain Res; 2014 May; 265():188-97. PubMed ID: 24583188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of nicotine taking and seeking in rats by the stoichiometry-selective alpha4beta2 nicotinic acetylcholine receptor positive allosteric modulator NS9283.
    Maurer JJ; Sandager-Nielsen K; Schmidt HD
    Psychopharmacology (Berl); 2017 Feb; 234(3):475-484. PubMed ID: 27844094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The GABA
    Augier E; Dulman RS; Damadzic R; Pilling A; Hamilton JP; Heilig M
    Neuropsychopharmacology; 2017 Aug; 42(9):1789-1799. PubMed ID: 28294133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in ethanol seeking and self-administration following yohimbine in selectively bred alcohol-preferring (P) and high alcohol drinking (HAD-2) rats.
    Bertholomey ML; Verplaetse TL; Czachowski CL
    Behav Brain Res; 2013 Feb; 238():252-8. PubMed ID: 23103404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mecamylamine attenuates cue-induced reinstatement of nicotine-seeking behavior in rats.
    Liu X; Caggiula AR; Yee SK; Nobuta H; Sved AF; Pechnick RN; Poland RE
    Neuropsychopharmacology; 2007 Mar; 32(3):710-8. PubMed ID: 16794568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide S differently modulates alcohol-related behaviors in alcohol-preferring and non-preferring rats.
    Cannella N; Kallupi M; Li HW; Stopponi S; Cifani C; Ciccocioppo R; Ubaldi M
    Psychopharmacology (Berl); 2016 Aug; 233(15-16):2915-24. PubMed ID: 27235017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.